Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
FATE | FATE THERAPEUTICS INC | Director | $146K | -$2.68K | -1.8% | Aug 6, 2024 |
AKRO | Akero Therapeutics, Inc. | Director | Jun 8, 2024 | |||
XLO | Xilio Therapeutics, Inc. | Director | Jun 14, 2024 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|